XML 64 R36.htm IDEA: XBRL DOCUMENT v3.3.1.900
Supplementary Quarterly Financial Information (unaudited) (Tables)
 12 Months Ended
Dec. 31, 2015
Supplementary Quarterly Financial Information (unaudited) [Abstract]  
Schedule of quarterly financial information
In thousands, except per share data)
 
First Quarter
 
Second Quarter
 
Third Quarter
 
Fourth Quarter
 
Year
2015
 
 
 
 
 
 
 
 
 
 
Revenues
 
$
10,849

 
$
13,590

 
$
11,309

 
$
15,420

 
$
51,168

Gross profit
 
5,281

 
6,689

 
4,537

 
8,191

 
24,698

Loss from operations
 
(4,572
)
 
(2,265
)
 
(4,877
)
 
(4,957
)
 
(16,671
)
Net loss
 
(4,862
)
 
(2,152
)
 
(4,416
)
 
(4,910
)
 
(16,340
)
Net loss per share (Basic and Diluted)
 
(0.27
)
 
(0.16
)
 
(0.26
)
 
(0.28
)
 
(0.97
)
2014
 
 
 
 
 
 
 
 
 
 
Revenues(a)
 
$
—

 
$
4,432

 
$
9,658

 
$
14,706

 
$
28,796

Gross profit (loss)
 
—

 
(577
)
 
4,126

 
7,954

 
11,503

Loss from operations
 
(4,645
)
 
(8,522
)
 
(8,022
)
 
(2,345
)
 
(23,534
)
Net loss(b)
 
(5,995
)
 
(4,638
)
 
(6,917
)
 
(2,370
)
 
(19,920
)
Net loss per share (Basic and Diluted)
 
(1.26
)
 
(0.94
)
 
(0.82
)
 
(0.17
)
 
(2.23
)
 
 
 
 
 
 
 
 
 
 
 
(a) Revenue from commercial operations began in June 2014 following the acquisition of the CTRM business. Prior to June 2014, Vericel was a development stage entity.
 
 
 
 
 
 
 
 
 
 
 
(b) The net loss in the second quarter of 2014 includes a $3.5 million bargain purchase gain as a result of the CTRM business acquisition.